The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer.

Zhao H, Li R, Wang X, Lu X, Hu M, Zhang J, Zhao X, Song X, Liu Y

Open source

DOI
10.1186/s13048-020-00719-3
Published
2020 Sep 21
Container
Journal of ovarian research
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13048-020-00719-3,
  title = {The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer.},
  author = {Zhao H and Li R and Wang X and Lu X and Hu M and Zhang J and Zhao X and Song X and Liu Y},
  year = {2020},
  journal = {Journal of ovarian research},
  doi = {10.1186/s13048-020-00719-3},
  url = {https://doi.org/10.1186/s13048-020-00719-3}
}

RIS

TY  - JOUR
TI  - The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer.
AU  - Zhao H
AU  - Li R
AU  - Wang X
AU  - Lu X
AU  - Hu M
AU  - Zhang J
AU  - Zhao X
AU  - Song X
AU  - Liu Y
PY  - 2020
JO  - Journal of ovarian research
DO  - 10.1186/s13048-020-00719-3
UR  - https://doi.org/10.1186/s13048-020-00719-3
ER  - 

APA

H, Z., R, L., X, W., X, L., M, H., J, Z., X, Z., X, S., & Y, L. (2020). The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer.. Journal of ovarian research. https://doi.org/10.1186/s13048-020-00719-3

Source records